128 related articles for article (PubMed ID: 769527)
1. Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.
Karlberg BE; Kågedal B; Tegler L; Tolagen K; Bergman B
Am J Cardiol; 1976 Mar; 37(4):642-9. PubMed ID: 769527
[TBL] [Abstract][Full Text] [Related]
2. Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.
Karlberg BE; Kågedal B; Tegler L; Tolagen K
Br Med J; 1976 Jan; 1(6004):251-4. PubMed ID: 764929
[TBL] [Abstract][Full Text] [Related]
3. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
Kralberg BE; Tolagen K
Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504
[TBL] [Abstract][Full Text] [Related]
4. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
Drayer JI; Kloppenborg PW; Festen J; van't Laar A; Benraad TJ
Am J Cardiol; 1975 Oct; 36(5):716-21. PubMed ID: 1103606
[TBL] [Abstract][Full Text] [Related]
5. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
Espiner EA; Mansfield H; Miles K
N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
[No Abstract] [Full Text] [Related]
6. The effect of spironolactone (Aldactone) and methyldopa in low and normal renin hypertension.
Solheim SB; Sundsfjord JA; Giezendanner L
Acta Med Scand; 1975 Jun; 197(6):451-6. PubMed ID: 1098396
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of essential hypertension with propranolol (author's transl)].
Klumpp F; Braun B; Klaus D; Lemke R; Zehner J
Dtsch Med Wochenschr; 1976 Oct; 101(41):1482-8. PubMed ID: 183943
[TBL] [Abstract][Full Text] [Related]
8. Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension.
Hollifield JW
South Med J; 1976 Aug; 69(8):1034-6. PubMed ID: 785608
[TBL] [Abstract][Full Text] [Related]
9. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
Klump F; Braun B; Klaus D; Lemke R; Zehner J; Zöfel P
Dtsch Med Wochenschr; 1975 Mar; 100(12):577-84. PubMed ID: 1168122
[TBL] [Abstract][Full Text] [Related]
10. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
Douglas JG; Hollifield JW; Liddle GW
JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
[No Abstract] [Full Text] [Related]
11. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
Hunyor SN; Zweifler AJ; Hansson L; Schork MA; Ellis C
Aust N Z J Med; 1975 Feb; 5(1):17-24. PubMed ID: 1057909
[TBL] [Abstract][Full Text] [Related]
12. Propranolol, renin and hypertension: a review.
Laragh JH; Bühler FR
Postgrad Med J; 1976; 52 Suppl 4(604):109-15. PubMed ID: 787950
[TBL] [Abstract][Full Text] [Related]
13. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive and renin angiotensin effects of metolazone with and without propranolol.
Sambhi MP; Eggena P; Barrett JD; Thananopavarn C; Tuck M; Wiedman C
J Clin Pharmacol; 1977 Apr; 17(4):214-24. PubMed ID: 849995
[TBL] [Abstract][Full Text] [Related]
15. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
Thomas GW; Ledingham JG; Beilin LJ; Yeates KM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):44-8. PubMed ID: 798576
[TBL] [Abstract][Full Text] [Related]
16. Low-renin hypertension. Restoration of normotension and renin responsiveness.
Spark RF; O'Hare CM; Regan RM
Arch Intern Med; 1974 Feb; 133(2):205-11. PubMed ID: 4591266
[No Abstract] [Full Text] [Related]
17. [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
Ebel H; Lübke H; Klaus D; Zehner J; Witzgall H
Dtsch Med Wochenschr; 1978 Oct; 103(42):1650-5. PubMed ID: 699788
[TBL] [Abstract][Full Text] [Related]
18. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.
Leonetti G; Mayer G; Morganti A; Terzoli L; Zanchetti A; Bianchetti G; Di Salle E; Morselli PL; Chidsey CA
Clin Sci Mol Med Suppl; 1975 Jun; 48(6):491-9. PubMed ID: 1056279
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
Morgan TO; Roberts R; Carney SL; Louis WJ; Doyle AE
Br J Clin Pharmacol; 1975 Apr; 2(2):159-64. PubMed ID: 791319
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive responses to spironolactone in normal renin hypertension.
Ogilvie RI; Piafsky KM; Ruedy J
Clin Pharmacol Ther; 1978 Nov; 24(5):525-30. PubMed ID: 699476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
